NP / PA
Premier Care Pediatrics, LLC
Premier Care Pediatrics, LLC was paid $1.99M by Medicaid between Jan 2018 and Dec 2024, across 39 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 30% of everything it billed.
33Billing provider infoPREMIER CARE PEDIATRICS, LLC
GREAT FALLS, MT 59405
GREAT FALLS, MT 59405
33aNPI1215361761assigned 09/01/2013
33bProvider typePediatric Nurse Practitioner
28Total paid$1.99M
24GClaims30,082
24DCodes billed39
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,587 | $403K | |
| 2019 | 5,924 | $363K | |
| 2020 | 3,970 | $242K | |
| 2021 | 4,239 | $276K | |
| 2022 | 3,950 | $275K | |
| 2023 | 2,677 | $211K | |
| 2024incomplete | 2,735 | $221K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 30% | 6,579 | 6,094 | $601K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 13% | 2,074 | 2,051 | $253K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 13% | 2,059 | 2,019 | $252K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 11% | 4,701 | 4,626 | $228K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 9.2% | 1,588 | 1,577 | $183K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.3% | 1,281 | 1,238 | $164K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.9% | 730 | 723 | $98K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.5% | 961 | 933 | $51K |
| 90670 | 1.6% | 1,369 | 1,363 | $32K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 827 | 816 | $18K |
| 90651 | <1% | 265 | 259 | $15K | |
| 90698 | <1% | 919 | 913 | $13K |
27 more codes
| 90710 | <1% | 148 | $11K | |
| 90461 | <1% | 147 | $9K | |
| 90680 | <1% | 766 | $8K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 385 | $6K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 396 | $6K |
| 90686 | <1% | 1,881 | $6K | |
| 96127 | <1% | 842 | $6K | |
| 99381 | <1% | 40 | $5K | |
| 90734 | <1% | 113 | $4K | |
| 90633 | <1% | 498 | $3K | |
| 90697 | <1% | 306 | $3K | |
| 90696 | <1% | 146 | $3K | |
| 90677 | <1% | 107 | $1K | |
| 90621 | <1% | 15 | $1K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 103 | $1K |
| 90619 | <1% | 30 | $1K | |
| 90744 | <1% | 294 | $937.10 | |
| 90707 | <1% | 26 | $812.64 | |
| 90685 | <1% | 211 | $805.16 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 20 | $717.30 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 14 | $456.17 |
| 96380 | <1% | 13 | $387.28 | |
| 90656 | <1% | 147 | $358.08 | |
| D1206 | Topical application of fluoride varnish | <1% | 17 | $323.71 |
| 90715 | <1% | 26 | $309.96 | |
| 83655 | <1% | 25 | $302.75 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 13 | $8.58 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGARVER, MICHAEL (CEO)